NIAID Small Business Biodefense Program—FY2007 Awards
| Institution |
PI Name |
Title |
| Akonni Biosystems, Inc. |
Chandler, Darrell P. |
Diagnostic Protein Array for Respiratory Infections |
| Akonni Biosystems, Inc. |
Chandler, Darrell P. |
Integrated, On-Chip Rt-Mme-Pcr for Influenza Diagnostics; Phase 1 = Sample Prepar |
| Aureogen Biosciences, Inc. |
Elhammer, Ake P. |
A Bacitracin Derivative for Systemic Use |
| Bcr Diagnostics |
Rotman, Boris |
Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing |
| Biotex, Inc. |
Jackson, George W. |
Rapid Microbial Identification by Maldi-Tof Mass Spectrometry of Ribosomal Rna |
| Cellex, Inc. |
Li, Xing-Xiang |
An Affinity Column for Influenza Virus Vaccine Manufacturing |
| Centrose, LLC |
Hutchinson, Charles R. |
Novel Macrolides as Anti-Infective Drugs |
| Emetagen, LLC |
Urbach, Ena |
Antibiotics from Soil DNA Clone Libraries: Selection of Anti-Mrsa Lead Compounds |
| Epivax, Inc. |
De Groot, Anne Searls |
Optimization of a Multivalent Tuberculosis Vaccine |
| Id Fish Technology, Inc. |
Shah, Jyotsna S. |
Tb-Fish Assay for Direct Detection Of M. Tuberculosis in Unprocessed Sputum |
| Idx Labs, LLC |
Houpt, Eric R. |
Targeted DNA Extraction for Tuberculosis Pcr from Sputum |
| Immunotope, Inc. |
Philip, Ramila |
Defining T Cell Epitopes in Dengue Virus Infection |
| Inbios International, Inc. |
Houghton, Raymond |
Rapid Antigen Detection Test for Dengue Infection |
| Innovative Biologics, Inc. |
Karginov, Vladimir A. |
Small Molecule Inhibitors of C. Perfringens Epsilon-Toxin |
| Integral Molecular |
Harris, Eva |
Dengue Reporter Virus Neutralization Assay for Clinical Studies |
| Investigen, Inc. |
Koshinsky, Heather A. |
Rapid, Easy Nucleic Acid-Based Detection of Pulmonary Tuberculosis |
| Inviragen, LLC |
Stinchcomb, Dan T. |
Mva-Based Vaccines against Highly Pathogenic Avian Influenza |
| Lancell, LLC |
Cowing, Carol O. |
Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines |
| Litron Laboratories, Ltd. |
Dertinger, Stephen D. |
High-Throughput Radiation Biodosimetry |
| Mapp Biopharmaceutical, Inc. |
Zeitlin, Larry |
A Monoclonal Antibody Immunoprotectant for Ebola Virus |
| Medivas, LLC |
Defife, Kristin Marie |
Immunogenicity Testing of a Fully Synthetic Subunit Vaccine against Influenza |
| Mercia Pharma, Inc. |
Blackburn, Peter |
Adjuvanted Influenza Vaccine |
| Microbiotix, Inc. |
Lory, Stephen |
Tlr5 Antagonists for Infectious Disease Therapy |
| Microbiotix, Inc. |
Peet, Norton P. |
Quinoline-Based Inhibitors of Botulinum Neurotoxin A |
| Microbiotix, Inc. |
Peet, Norton P. |
Inhibition of Ebola Virus Infection with Cathepsin L Inhibitors |
| Najit Technologies, Inc. |
Fitchen, John |
Rapid Diagnosis of Monkeypox and Smallpox Infections |
| Nature Technology Corporation |
Williams, James |
Rapid Deployment DNA Vaccine for Pandemic Influenza |
| Nirvana Pharmaceuticals, Inc. |
Lindsey, Jonathan Sidney |
Stable Cationic Bacteriochlorins for Antimicrobial Photodynamic Therapy |
| Novadigm Therapeutics, Inc. |
Yeaman, Michael R. |
Novel Context-Activated Protide Anti-Infectives |
| Novobiotic Pharmaceuticals, LLC |
Moore, Charles Michael |
Isolating Novel Fungi for Antibiotic Discovery |
| Panthera Biopharma, LLC |
Lehrer, Axel T. |
Development of a Recombinant Subunit Ebola Vaccine |
| Panthera Biopharma, LLC |
Johnson, Alan Thomas |
Inhibitors of Anthrax Lethal Factor Metalloproteinase |
| Rocky Mountain Biosystems, Inc. |
Marchitto, Kevin |
Self-Administered Vaccination Electromechanical Device for Influenza |
| Seralogix |
Drake, Kenneth L. |
Bwa Host-Pathogen Innate Immune S/W Analysis Tools |
| Sibtech, Inc. |
Backer, Marina V. |
Targeted Delivery of Anthrax Inhibitors |
| Siga Technologies, Inc. |
Hruby, Dennis E. |
Enhancing the Immune Response to Antigens Delivered by the Bacterial Vector, Stre |
| Siga Technologies, Inc. |
Grosenbach, Douglas W. |
St-246 Treatment of Smallpox Vaccine-Related Adverse Events in Murine Models |
| Soymeds, Inc. |
Piller, Kenneth J. |
A Novel Therapy for Staphyloccocal Enterotoxin B Poisoning |
| Syntiron, LLC |
Herron-Olson, Lisa |
Yersinia Membrane Proteins as Vaccine Candidates |
| Techlab, Inc. |
Carman, Robert James |
Mucin-Degrading Microflora for Prophylactic Antibiotics |
| Tsrl, Inc. |
Hilfinger, John M. |
Vidarabine Prodrugs as Anti-Pox Virus Agents |
| Tsrl, Inc. |
Hilfinger, John M. |
Improving Absorption and Targeting of Antiviral Drugs |
| Vaxinnate Corporation |
Mcdonald, William F. |
Development of a Tetravalent Dengue Vaccine That Links Innate and Adaptive Immuni |
| Vectorlogics, Inc. |
Hedley, Susan J. |
Development of Shielded Adenovirus Vector as a Vaccine Strategy for Anthrax |
| Virogenomics, Inc. |
Heffron, Fred L. |
Genetically Defined Attenuated Living Vaccine for Francisella |
| Vital Probes, Inc. |
Delvecchio, Vito G. |
Development of a Bacterial Ghost DNA Vaccine for Influenza Using Antibody Epitope |
| West Coast Biologicals, Inc. |
Tucker, Sean N. |
Enhanced Oral Vaccine Delivery Vehicle |
back to top |